Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

473
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
473
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

26
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
26
Testing a Claim about Population Proportion01:24

Testing a Claim about Population Proportion

3.5K
A complete procedure for testing a claim about a population proportion is provided here.
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
3.5K
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

34
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
34
Sample Proportion and Population Proportion01:20

Sample Proportion and Population Proportion

5.8K
Collecting samples or responses from an entire population takes significant time and effort, so a researcher collects responses from only a sample of that population. Suppose a study needs to collect information about a specific mobile application. After sample collection, the researcher analyzes the data and discovers that most individuals in the sample use that specific mobile application. The sample proportion measures the number of individuals in a sample who either use or don't use the...
5.8K
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

25
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
25

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An exploratory analysis of interaction effects in EQ-5D valuation using saturated EQ VAS datasets from the Netherlands, the United Kingdom, and China.

Health and quality of life outcomes·2026
Same author

Development Process of a Clinical Decision Support System for Empiric Antibiotic Therapies in Patients With Sepsis: Case Study.

JMIR medical informatics·2026
Same author

Financial influences and the primacy of patient welfare - an empirical and ethical analysis in German cancer medicine.

BMC medical ethics·2026
Same author

Enhancing Continuous Medication Safety Through e-Prescription and Clinical Decision Support Systems in Outpatient Practices and Pharmacies: Protocol for a Multiperspective Study (eRIKA Study).

JMIR research protocols·2026
Same author

Epidemiology and economic burden of medically attended influenza and influenza-like illness in Germany, 2016-2019.

Journal of medical economics·2026
Same author

The role of financial distress as a patient-relevant endpoint in early benefit assessments for oncology drugs: a mixed-methods document analysis.

International journal of technology assessment in health care·2026

Related Experiment Video

Updated: Oct 22, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.5K

To What Extent Do Patient Preferences Differ From General Population Preferences?

Kristina Ludwig1, Juan M Ramos-Goñi2, Mark Oppe3

  • 1Department of Health Economics and Health Care Management, School of Public Health, Bielefeld University, Bielefeld, Germany.

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|August 28, 2021
PubMed
Summary

Patient health preferences differ from general population views, prioritizing functional aspects over symptoms. These differences vary by country and disease, suggesting a need to incorporate patient perspectives in healthcare economic evaluations.

Keywords:
EQ-5D-5Ldiscrete choice experimentgeneral population preferenceshealth-related quality of lifepatient preferencesvaluation

More Related Videos

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.2K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.8K

Related Experiment Videos

Last Updated: Oct 22, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.5K
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.2K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.8K

Area of Science:

  • Health Economics
  • Patient-Reported Outcomes
  • Preference Elicitation

Background:

  • Healthcare decision-making often relies on general population preferences for health states.
  • The validity of using general population preferences is questioned when patient perspectives differ significantly.

Purpose of the Study:

  • To investigate differences between patient and general population health preferences.
  • To explore methods for integrating both patient and general population preferences in economic evaluations.

Main Methods:

  • Utilized EQ-5D-5L general population preferences from national value sets in Germany and Spain.
  • Conducted discrete choice experiments with patients suffering from rheumatism and diabetes mellitus.
  • Employed an econometric approach based on the conditional logit framework, anchoring latent values with national value sets.

Main Results:

  • Analysis included 1700 patients across Germany and Spain.
  • Patients in both countries prioritized mobility, self-care, and usual activities over pain/discomfort and anxiety/depression compared to the general population.
  • The magnitude of these preference differences was greater in Germany than in Spain.

Conclusions:

  • Patient preferences demonstrably diverge from general population preferences, with a greater emphasis on functional dimensions.
  • The extent of these divergences is influenced by specific diseases and national contexts.
  • Proposed a method for incorporating patient perspectives into health state valuation for countries prioritizing patient preferences.